Chohee Yun

Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

Brian G. Feagan, Silvio Danese, Edward V. Loftus et al. · The Lancet · 2021 · 437 citations

Medicine, Clinical Sciences, Pharmacotherapy +15

NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome

Stefan Zeuzem, Masashi Mizokami, Stephen Pianko et al. · Journal of Hepatology · 2017 · 203 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

Treatment With Ledipasvir–Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection

Massimo Colombo, Alessio Aghemo, Jie Zhang et al. · Annals of Internal Medicine · 2016 · 183 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV

Chun‐Jen Liu, Wan‐Long Chuang, I‐Shyan Sheen et al. · Gastroenterology · 2017 · 118 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

Jason Grebely, Stefan Mauss, Ashley Brown et al. · Clinical Infectious Diseases · 2016 · 100 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17